Data to be presented by Dr. Robert F. Kushner, Professor Emeritus of Endocrinology, Metabolism and Molecular Medicine at Northwestern Feinberg School of Medicine, Chicago, show that treatment with ...
Contrave aims for success where many others have failed. July 30, 2010 -- There may be new hope for people looking for a diet pill that's both safe and effective. Researchers found that participants ...
SAN DIEGO, Nov. 25, 2013 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced successful results of the interim analysis of the Light Study. Based on these results, the Company ...
Doctors mainly positive about new drug combo for daily diet pill. July 21, 2009— -- Finding the perfect pill, procedure, or injection to make people lose weight might sound as lofty a goal as ...
Contrave and Wegovy are medications prescribed for long-term weight management. Contrave is an oral tablet you take twice daily, and Wegovy is an injectable solution you receive once weekly. Both ...
These statements are based on the Companies' current beliefs and expectations. These forward-looking statements include statements regarding: the timing of Takeda's commercial launch of Contrave in ...
Forbes contributors publish independent expert analyses and insights. I report the latest in health, nutrition, wellness and healthy travel. Will the FDA finally approve Contrave, Orexigen’s hot new ...
Contrave is a brand-name medication that contains the drugs naltrexone and bupropion. It’s prescribed to help adults lose weight when combined with diet and exercise. Over the first 4 weeks of use, ...
Data to be shared during an ObesityWeek press conference include four of seven presentations supporting CONTRAVE and its utility in helping people lose weight BRENTWOOD, Tenn., Nov. 4, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results